Vir Biotechnology, Inc. VIR

10.66 (0.06) (0.56%) as of 25 Sep
Market cap
$1.8B
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Net Income
(251.68) (442.72) (437.99) (499.65)

+8 more TTM periods

Depreciation & Amortization
15.09 17.40 21.15 21.76
Non Cash Items (Other)
56.74 50.45 47.50 60.96
Accounts Payable Change
5.64 2.19 5.00 0.11
Change in payables and accrued liability
(10.34) (44.74) (9.51) (68.10)
Change in other assets and liabilities
(17.95) (28.63) (17.93) 31.39
Operating Cash Flow
(202.51) (446.05) (391.78) (453.54)
Capital expenditures
(1.16) (3.62) (4.58) (3.66)
Short Term Investments Change (Net)
(57.05) 199.01 314.95 368.12
Investing cash flow
(58.21) 195.39 310.37 364.46
Equity Repurchase (Common, Net)
242.04 166.07 4.15 4.36
Other financial activities
— — (0.35) (0.39)
Financing cash flow
242.04 165.71 3.79 4.01
Change in Cash
(18.68) (84.95) (77.62) (85.07)
Beginning Cash
241.07 241.07 318.70 318.70
Ending Cash
222.39 156.12 241.07 233.62
Stock Based Compensation
47.04 47.10 49.07 53.71
Dividends Paid (Common)
0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(22.66) (71.19) (22.45) (36.60)
Investments Change (Net)
(57.05) 199.01 314.95 368.12
Issuance/Purchase of Shares
242.04 166.07 4.15 4.36

Fold the line items

In millions of $ except per-share values · columns are period end dates